TY - JOUR
T1 - MR and PET-CT monitoring of tissue-engineered vascular grafts in the ovine carotid artery
AU - Wolf, Frederic
AU - Paefgen, Vera
AU - Winz, Oliver
AU - Mertens, Marianne
AU - Koch, Sabine
AU - Gross-Weege, Nicolas
AU - Morgenroth, Agnieszka
AU - Rix, Anne
AU - Schnoering, Heike
AU - Chalabi, Khaled
AU - Jockenhoevel, Stefan
AU - Lammers, Twan
AU - Mottaghy, Felix
AU - Kiessling, Fabian
AU - Mela, Petra
N1 - Publisher Copyright:
© 2019 Elsevier Ltd
PY - 2019/9
Y1 - 2019/9
N2 - The modification of biomaterials to comply with clinically employed monitoring techniques is a promising strategy to support clinical translation in regenerative medicine. Here, multimodal imaging of tissue-engineered vascular grafts (TEVG) was enabled by functionalizing the textile scaffold with ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. The resulting MR-imageable grafts (iTEVG) were monitored non-invasively throughout their whole life-cycle, from initial quality control to longitudinal functional evaluation in an ovine model for up to 8 weeks. Crucial features such as the complete embedding of the textile mesh in the developing tissue and the grafts’ structural stability were assessed in vitro using 1T-, 3T- and 7T-MRI scanners. In vivo, the grafts were imaged by 3T-MRI and PET-CT. Contrary to unlabeled constructs, iTEVG could be delineated from native arteries and precisely localized by MRI. USPIO labeling neither induced calcifications, nor negatively affected their remodeling with respect to tissue-specific extracellular matrix composition and endothelialization. Functionality was confirmed by MR-angiography. 18F-FDG uptake (assessed via PET-CT) indicated only transient post-surgical inflammation. In conclusion, USPIO-labeling enables accurate localization of TEVG and opens up opportunities for multimodal imaging approaches to assess transplant acceptance and function. Thereby, it can support clinical decision-making on the need for further pharmacological or surgical interventions.
AB - The modification of biomaterials to comply with clinically employed monitoring techniques is a promising strategy to support clinical translation in regenerative medicine. Here, multimodal imaging of tissue-engineered vascular grafts (TEVG) was enabled by functionalizing the textile scaffold with ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. The resulting MR-imageable grafts (iTEVG) were monitored non-invasively throughout their whole life-cycle, from initial quality control to longitudinal functional evaluation in an ovine model for up to 8 weeks. Crucial features such as the complete embedding of the textile mesh in the developing tissue and the grafts’ structural stability were assessed in vitro using 1T-, 3T- and 7T-MRI scanners. In vivo, the grafts were imaged by 3T-MRI and PET-CT. Contrary to unlabeled constructs, iTEVG could be delineated from native arteries and precisely localized by MRI. USPIO labeling neither induced calcifications, nor negatively affected their remodeling with respect to tissue-specific extracellular matrix composition and endothelialization. Functionality was confirmed by MR-angiography. 18F-FDG uptake (assessed via PET-CT) indicated only transient post-surgical inflammation. In conclusion, USPIO-labeling enables accurate localization of TEVG and opens up opportunities for multimodal imaging approaches to assess transplant acceptance and function. Thereby, it can support clinical decision-making on the need for further pharmacological or surgical interventions.
KW - MRI
KW - Multimodal monitoring
KW - Non-invasive monitoring
KW - PET-CT
KW - Tissue-engineered vascular graft
KW - USPIO
UR - http://www.scopus.com/inward/record.url?scp=85066947389&partnerID=8YFLogxK
U2 - 10.1016/j.biomaterials.2019.119228
DO - 10.1016/j.biomaterials.2019.119228
M3 - Article
C2 - 31195299
AN - SCOPUS:85066947389
SN - 0142-9612
VL - 216
JO - Biomaterials
JF - Biomaterials
M1 - 119228
ER -